Open Access
Review
Metabolomics in Cardiovascular Diseases
Shan Lu1, †
Zisheng Huang2, †
Baitao Liu3
Yan Zhang1, *
Author Information
Submitted: 10 Jul 2023 | Revised: 25 Sept 2024 | Accepted: 26 Sept 2024 | Published: 25 Oct 2024

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and disorders of cardiac energy metabolism are the main contributors to many cardiovascular pathologies. Metabolomics is a science that examines the types and amounts of metabolites and the patterns of change in biological systems after stimulation or perturbation. Metabolites are widely distributed in the body and have universal regulatory effects on a wide range of physiological activities. Metabolism is at the end of the regulation of life activities, so metabolomics is closer to phenotypes than genomics and transcriptom-ics, and can reflect the state of biological systems more accurately. Metabolomics, a cross-cutting dis-cipline emerging in the post-genomics era, has rapidly penetrated into many fields of medicine, im-proves understanding of complex diseases and generates more new discoveries and hypotheses. Therefore, metabolomics helps detect metabolic changes in the course of CVDs, search for biomarkers, and further study the pathogenesis of CVDs. In this review, we intend to comprehensively summarize the principles, classification and applications in CVDs of metabolomics.

References

Share this article:
Graphical Abstract
How to Cite
Lu, S., Huang, Z., Liu, B., & Zhang, Y. (2024). Metabolomics in Cardiovascular Diseases. International Journal of Drug Discovery and Pharmacology, 3(4), 100019. https://doi.org/10.53941/ijddp.2024.100019
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2024 by the authors.

This work is licensed under a This work is licensed under a Creative Commons Attribution 4.0 International License.